Privia Health (PRVA) director awarded 8,463 RSUs in equity grant

Rhea-AI Filing Summary

Kimmet Pamela O reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group director Pamela O. Kimmet received a grant of 8,463 restricted stock units under the company’s 2021 Omnibus Incentive Plan on May 20, 2026. These RSUs vest on the earlier of the day before the 2027 annual shareholder meeting or one year after the grant. After this grant, she holds 34,172 common shares directly. This is a compensation-related award, not an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kimmet Pamela O

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	8,463	$0.00	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 34,172 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 8,463 units Shares held after grant: 34,172 shares Grant price per unit: $0.00 per unit

3 metrics

RSU grant size 8,463 units Restricted stock units granted May 20, 2026

Shares held after grant 34,172 shares Common stock directly held after transaction

Grant price per unit $0.00 per unit Equity award, no purchase price paid

Key Terms

restricted stock units, 2021 Omnibus Incentive Plan, annual meeting of stockholders

3 terms

restricted stock units financial

"the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2021 Omnibus Incentive Plan financial

"received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

annual meeting of stockholders financial

"will vest on the earlier of the day immediately preceding the Company's 2027 annual meeting of stockholders"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kimmet Pamela O

(Last) (First) (Middle)

PRIVIA HEALTH GROUP, INC.

950 N. GLEBE ROAD, SUITE 700

(Street)

ARLINGTON VIRGINIA 22203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/20/2026		A		8,463(1)	A	$0	34,172	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

Remarks:

	/s/ Anita Beth Adams, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Privia Health Group (PRVA) director Pamela O. Kimmet receive in this Form 4?

Pamela O. Kimmet received 8,463 restricted stock units as an equity award. The grant was made under Privia Health Group’s 2021 Omnibus Incentive Plan as part of her director compensation, rather than through an open‑market stock purchase.

When do Pamela O. Kimmet’s 8,463 Privia Health (PRVA) RSUs vest?

The 8,463 restricted stock units vest on the earlier of two dates. Vesting occurs either the day immediately before Privia Health Group’s 2027 annual stockholder meeting or on the first anniversary of the May 20, 2026 grant date.

How many Privia Health (PRVA) shares does Pamela O. Kimmet hold after this transaction?

Following the equity award, Pamela O. Kimmet holds 34,172 shares of Privia Health common stock directly. This figure reflects her ownership after receiving the 8,463 restricted stock units disclosed in the Form 4 filing.

Was Pamela O. Kimmet’s Privia Health (PRVA) Form 4 a stock purchase or a grant?

The Form 4 reports a grant, not a purchase. The transaction code “A” shows she acquired 8,463 restricted stock units as a compensation award with a zero-dollar price per unit, rather than buying shares in the open market.

Under which plan were Pamela O. Kimmet’s Privia Health (PRVA) RSUs granted?

The 8,463 restricted stock units were granted under Privia Health Group’s 2021 Omnibus Incentive Plan. This plan is used to provide equity-based compensation to eligible participants, including directors such as Pamela O. Kimmet.